COVID-19 May Briefing: The UK&I Healthcare Ecosystem FightbackThe third webinar* in the COVID-19 monthly briefing series was designed to provide insight from life sciences thought-leaders Share XCOVID-19 May Briefing: The UK&I Healthcare Ecosystem Fightbackhttps://pharmaphorum.com/r-d/covid-19-may-briefing-the-uki-healthcare-ecosystem-fightback/
The new global digital health paradigm in life sciencesDigital transformation has long been a priority for all life science companies and it has been made even Share XThe new global digital health paradigm in life scienceshttps://pharmaphorum.com/r-d/10-years-in-10-days-the-new-global-digital-health-paradigm-in-life-sciences/
COVID-19 briefing: coronavirus impacts for UK and Ireland pharma and biotechOverview This April webinar is part of IQVIA’s monthly updates on the impact of COVID-19 and its implications Share XCOVID-19 briefing: coronavirus impacts for UK and Ireland pharma and biotechhttps://pharmaphorum.com/r-d/iqvia-covid-19-april-briefing-impact-for-pharma-and-biotech/
Vaccines trials in the COVID-19 era and tech’s role in speeding studiesOverview The COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus Share XVaccines trials in the COVID-19 era and tech’s role in speeding studieshttps://pharmaphorum.com/r-d/vaccines-trials-covid-19-coronavirus/
The COVID-19 coronavirus and pharma and biotech continuity planningOverview Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from Share XThe COVID-19 coronavirus and pharma and biotech continuity planninghttps://pharmaphorum.com/r-d/the-potential-impact-of-coronavirus-covid-19-for-global-pharma-and-biotech-continuity/
Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?Helping someone live with a condition as complex as MS can be fraught with challenges. MS professionals are Share XDigital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?https://pharmaphorum.com/debates-insight-digital/digital-health-can-technology-used-engage-hard-reach-patients-assist-patient-monitoring/
20/06/2017Disruption and maturity: the future directions for biologicsIs the UK’s NHS saving enough from the new wave of biosimilars? Share XDisruption and maturity: the future directions for biologicshttps://pharmaphorum.com/debates-insight-market-access/disruption-maturity-future-directions-biologics/
The future of the clinical trial: collaboration and patient centricity Growing patient influence combined with new technologies and the requirements of new reimbursement models means clinical research Share XThe future of the clinical trial: collaboration and patient centricityhttps://pharmaphorum.com/debates-insight-patients/future-clinical-trial-collaboration-patient-centricity/
10/03/2017Approval and access: overcoming the final hurdle of drug development2017 is likely to be a year of significant change for pharma brands in Europe. With affordability on the agenda for Share XApproval and access: overcoming the final hurdle of drug developmenthttps://pharmaphorum.com/debates-insight-market-access/european-market-access-overcoming-final-hurdle-drug-development/